Elevated frequencies of CD39+PD-1+ regulatory T cells (Tregs) in both peripheral blood and tumor tissues reflect a systemic immunosuppressive state and are strongly associated with disease progression, recurrence, and reduced overall survival (78, 79). This evidence concerns the gene ENTPD1 and neoplasm.